University of Rochester

Drug shows promise for Huntington's disease

An early stage clinical trial of the experimental drug dimebon (latrepirdine) in people with Huntington's disease appears to be safe and may improve cognition. That is the conclusion of a study published today in the Archives ...

dateFeb 08, 2010 in Neuroscience
shares0 comments 0

Impact of FDA safety warnings examined

A study published today in the Archives of Internal Medicine examines the impact of a safety warning issued by the Food and Drug Administration for commonly prescribed antipsychotic medications. The results show the warnings ...

dateJan 11, 2010 in Medications
shares0 comments 0